HIV prevention implant: patients and doctors share their hopes and concerns

NCT ID NCT05420207

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study interviewed 69 men who have sex with men (MSM) and their primary care doctors in Texas to understand their views on a future long-acting, implantable HIV prevention method (LA-PrEP). The goal was to identify what might help or hinder people from using such an implant and what training doctors would need. No actual implant was given; this was purely a research study to gather opinions and guide future development.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dell Medical School, UT-Austin

    Austin, Texas, 78712, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15261, United States